Which of the following statements about pegfilgrastim is true?
PEGFILGRASTIM:- Long acting granulocyte colony stimulating factor (GCSF). It is used along with anticancer drug to decrease neutropenia. Commonly given by SC route. Drug ending with GRASTIM are granulocytes stimulator. Drug ending with GRAMOSTIM are granulocyte monocyte stimulator. Eg:- SARGRAMOSTIM.
It decrease the risk of neutropenia in patients on anti cancer therapy
It is a sho acting drug
It can be given orally
It is recombinant GM CSF
Cytotoxic Anticancer Drugs